Common Contracts
4 similar Executive Employment Agreement contracts by Precision Biosciences Inc
EXECUTIVE EMPLOYMENT AGREEMENT AMENDMENTExecutive Employment Agreement • November 8th, 2022 • Precision Biosciences Inc • Biological products, (no disgnostic substances)
This Executive Employment Agreement Amendment (the “Amendment”) is made as of November 7, 2022, by and among Precision BioSciences, Inc. (the “Company”) and the individual whose name appears on the signature page hereto (the “Executive”). Except as set forth in this Amendment, capitalized terms used but not defined herein shall have the meanings ascribed to them in the Employment Agreement (as defined below).
EXECUTIVE EMPLOYMENT AGREEMENT AMENDMENTExecutive Employment Agreement • November 8th, 2022 • Precision Biosciences Inc • Biological products, (no disgnostic substances)
This Executive Employment Agreement Amendment (the “Amendment”) is made as of November 7, 2022, by and among Precision BioSciences, Inc. (the “Company”) and the individual whose name appears on the signature page hereto (the “Executive”). Except as set forth in this Amendment, capitalized terms used but not defined herein shall have the meanings ascribed to them in the Employment Agreement (as defined below).
EXECUTIVE EMPLOYMENT AGREEMENT AMENDMENTExecutive Employment Agreement • November 8th, 2022 • Precision Biosciences Inc • Biological products, (no disgnostic substances)
This Executive Employment Agreement Amendment (the “Amendment”) is made as of November 7, 2022, by and among Precision BioSciences, Inc. (the “Company”) and the individual whose name appears on the signature page hereto (the “Executive”). Except as set forth in this Amendment, capitalized terms used but not defined herein shall have the meanings ascribed to them in the Employment Agreement (as defined below).
EXECUTIVE EMPLOYMENT AGREEMENT AMENDMENTExecutive Employment Agreement • November 8th, 2022 • Precision Biosciences Inc • Biological products, (no disgnostic substances)
This Executive Employment Agreement Amendment (the “Amendment”) is made as of November 7, 2022, by and among Precision BioSciences, Inc. (the “Company”) and the individual whose name appears on the signature page hereto (the “Executive”). Except as set forth in this Amendment, capitalized terms used but not defined herein shall have the meanings ascribed to them in the Employment Agreement (as defined below).
